NO20013179L - Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter - Google Patents

Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Info

Publication number
NO20013179L
NO20013179L NO20013179A NO20013179A NO20013179L NO 20013179 L NO20013179 L NO 20013179L NO 20013179 A NO20013179 A NO 20013179A NO 20013179 A NO20013179 A NO 20013179A NO 20013179 L NO20013179 L NO 20013179L
Authority
NO
Norway
Prior art keywords
aromatic heterocycle
hiv integrase
inhibitory activities
heterocycle compounds
integrase inhibitory
Prior art date
Application number
NO20013179A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013179D0 (no
Inventor
Toshio Fujishita
Tomokazu Yoshinaga
Akihiko Sato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20013179D0 publication Critical patent/NO20013179D0/no
Publication of NO20013179L publication Critical patent/NO20013179L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20013179A 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter NO20013179L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP37127098 1998-12-25
JP24747999 1999-09-01
PCT/JP1999/007101 WO2000039086A1 (fr) 1998-12-25 1999-12-17 Composes heterocycliques aromatiques possedant des activites inhibitrices de l'integrase du vih

Publications (2)

Publication Number Publication Date
NO20013179D0 NO20013179D0 (no) 2001-06-22
NO20013179L true NO20013179L (no) 2001-08-27

Family

ID=26538287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013179A NO20013179L (no) 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Country Status (22)

Country Link
US (3) US6620841B1 (id)
EP (1) EP1142872B1 (id)
JP (1) JP3929244B2 (id)
KR (1) KR20010089708A (id)
CN (1) CN1178913C (id)
AP (1) AP2001002169A0 (id)
AT (1) ATE411286T1 (id)
AU (1) AU763040B2 (id)
BR (1) BR9916583A (id)
CA (1) CA2353961A1 (id)
CZ (1) CZ20012160A3 (id)
DE (1) DE69939749D1 (id)
HK (1) HK1042701A1 (id)
HU (1) HUP0201472A3 (id)
ID (1) ID29027A (id)
IL (1) IL143958A0 (id)
NO (1) NO20013179L (id)
NZ (1) NZ512184A (id)
PL (1) PL348596A1 (id)
RU (1) RU2225860C2 (id)
TR (1) TR200101886T2 (id)
WO (1) WO2000039086A1 (id)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380249B1 (en) 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
US6306891B1 (en) 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
GB9816358D0 (en) * 1998-07-27 1998-09-23 Angeletti P Ist Richerche Bio Enzyme inhibitors
US6492423B1 (en) 1998-07-27 2002-12-10 Istituto Di Ricerche Di Biologia Molecolare Pangeletti Spa Diketoacid-derivatives as inhibitors of polymerases
CA2376043A1 (en) * 1999-06-02 2000-12-14 Shionogi & Co., Ltd. Novel processes for the preparation of substituted propenone derivatives
JP2003503386A (ja) * 1999-06-25 2003-01-28 メルク エンド カムパニー インコーポレーテッド １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用
MXPA02012160A (es) * 2000-06-13 2003-04-25 Shionogi & Co Composiciones medicinales las cuales contienen derivados de propenona.
WO2001095905A1 (en) * 2000-06-14 2001-12-20 Shionogi & Co., Ltd. Inhibitor for enzyme having two divalent metal ions as active centers
AU2002212701A1 (en) * 2000-11-09 2002-05-21 Shionogi And Co., Ltd. Drug-tolerant hiv integrases
EP2181985B1 (en) * 2001-08-10 2011-10-26 Shionogi & Co., Ltd. Antiviral Agent
EP1441735B1 (en) * 2001-10-26 2006-02-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
TW200407132A (en) * 2001-11-15 2004-05-16 Shionogi & Co Process for producing 1-H-1,2,4-triazole-3-carboxylic acid ester
AU2002349675A1 (en) * 2001-12-05 2003-06-17 Shionogi And Co., Ltd. Derivative having hiv integrase inhibitory activity
US7358249B2 (en) 2002-08-13 2008-04-15 Shionogi & Co., Ltd. Heterocyclic compounds having inhibitory activity against HIV integrase
WO2004035577A2 (en) 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
CN1569803B (zh) * 2003-07-16 2011-04-13 中国科学院上海药物研究所 芳基β－二酮酸的新制备方法
US20060019952A1 (en) * 2004-01-29 2006-01-26 Elixir Pharmaceuticals, Inc. Anti-viral therapeutics
CA2578068C (en) * 2004-08-25 2011-08-09 Ardea Biosciences, Inc. S-triazolyl .alpha.-mercaptoacetanildes as inhibitors of hiv reverse transcriptase
WO2006030807A1 (ja) * 2004-09-15 2006-03-23 Shionogi & Co., Ltd. Ｈｉｖインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
CN101068533B (zh) * 2004-12-03 2011-04-27 默沙东公司 含有抗成核剂的药物组合物
US7250421B2 (en) * 2005-01-31 2007-07-31 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
WO2006129134A1 (en) * 2005-06-01 2006-12-07 Bioalliance Pharma Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents
AU2007254190A1 (en) 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
US7888375B2 (en) 2006-07-19 2011-02-15 The University Of Georgia Research Foundation, Inc Pyridinone diketo acids: inhibitors of HIV replication
WO2008041882A1 (fr) * 2006-10-03 2008-04-10 Viktor Veniaminovich Tets Procédé pour agir sur les virus au moyen d'une substance à base de 2,8-dithioxo-1h- pyrano[2,3-d;6,5-d'] dipyrimidine et de leurs analogues 10-aza (et variantes)
CN102670628B (zh) 2008-01-25 2015-11-25 奇默里克斯公司 治疗病毒感染的方法
WO2010047774A2 (en) * 2008-10-20 2010-04-29 The Texas A & M University System Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof
WO2011071849A2 (en) 2009-12-07 2011-06-16 University Of Georgia Research Foundation, Inc. Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
EP2534150B1 (en) 2010-02-12 2017-04-05 Chimerix, Inc. Methods of treating viral infection
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN101928258B (zh) * 2010-08-18 2014-10-29 杭州民生药业有限公司 1-(2-取代苯胺基-4-甲基-噻唑-5)-3-取代苯基-丙烯酮衍生物、制备方法及其制药用途
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
LT3067358T (lt) 2012-12-21 2019-11-25 Gilead Sciences Inc Policikliniai karbamoilpiridono junginiai ir jų farmacinis panaudojimas
NO2865735T3 (id) 2013-07-12 2018-07-21
SI3019503T1 (sl) 2013-07-12 2017-11-30 Gilead Sciences, Inc. Policiklične karbamoilpiridonske spojine in njihova uporaba za zdravljenje HIV infekcij
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (id) 2014-06-20 2018-06-23
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
SI3466490T1 (sl) 2015-04-02 2020-12-31 Gilead Sciences, Inc. Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba
CN106905244B (zh) * 2017-02-27 2019-08-16 武汉工程大学 二芳基嘧啶-二酮酸类杂合型hiv-1抑制剂及其制备方法
CN114829357A (zh) * 2019-10-28 2022-07-29 中国科学院上海药物研究所 五元杂环氧代羧酸类化合物及其医药用途
CN111943899B (zh) * 2020-09-08 2023-04-21 河北凯诺中星科技有限公司 一种5-甲酸乙酯四氮唑的合成方法
CN113683574B (zh) * 2021-09-06 2023-11-17 上海晋鲁医药科技有限公司 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899508A (en) 1974-04-12 1975-08-12 Lilly Co Eli 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
US3931247A (en) 1974-12-11 1976-01-06 Morton-Norwich Products, Inc. 5-(Substituted)phenylfurfuryl alcohols
JPS5811878B2 (ja) 1974-12-19 1983-03-04 大正製薬株式会社 フロ （ ３ ２−ｂ ） インド−ルルイノ セイホウ
JPS56100784A (en) 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4273776A (en) 1980-01-30 1981-06-16 E. R. Squibb & Sons, Inc. Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones
US4336397A (en) 1980-12-29 1982-06-22 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
US4423063A (en) 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
US4332735A (en) 1981-07-06 1982-06-01 Morton-Norwich Products, Inc. Antifungal compound
US4637829A (en) 1984-04-27 1987-01-20 Ciba-Geigy Corporation Sulfonylureas
JPS61134346A (ja) 1984-12-03 1986-06-21 Shionogi & Co Ltd ４−オキソカルボン酸誘導体および抗潰瘍剤
CA1334975C (en) 1987-11-13 1995-03-28 James H. Holms Furan and pyrrole containing lipoxygenase inhibiting compounds
JPH0238403A (ja) 1988-07-28 1990-02-07 Canon Inc 光重合性組成物および記録媒体
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
TW224974B (id) * 1991-07-02 1994-06-11 Hoffmann La Roche
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
US5475109A (en) 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
CN1254335A (zh) 1997-04-04 2000-05-24 辉瑞产品公司 烟酰胺衍生物
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
EP1069111A4 (en) 1998-03-26 2001-06-06 Shionogi & Co INDOLE DERIVATIVES EXER ANT ANTIVIRAL ACTIVITY
WO1999048371A1 (en) 1998-03-27 1999-09-30 The Regents Of The University Of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
WO1999062513A1 (en) 1998-06-03 1999-12-09 Merck & Co., Inc. Hiv integrase inhibitors
CA2333707A1 (en) 1998-06-03 1999-12-09 Melissa Egbertson Hiv integrase inhibitors
WO1999062897A1 (en) 1998-06-03 1999-12-09 Merck & Co., Inc. Hiv integrase inhibitors
JP2003503386A (ja) 1999-06-25 2003-01-28 メルク エンド カムパニー インコーポレーテッド １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用

Also Published As

Publication number Publication date
RU2225860C2 (ru) 2004-03-20
JP3929244B2 (ja) 2007-06-13
HK1042701A1 (zh) 2002-08-23
EP1142872B1 (en) 2008-10-15
WO2000039086A1 (fr) 2000-07-06
HUP0201472A2 (hu) 2003-10-28
US6620841B1 (en) 2003-09-16
AP2001002169A0 (en) 2001-06-30
PL348596A1 (en) 2002-06-03
ID29027A (id) 2001-07-26
DE69939749D1 (de) 2008-11-27
NZ512184A (en) 2003-08-29
US7098201B2 (en) 2006-08-29
KR20010089708A (ko) 2001-10-08
BR9916583A (pt) 2001-09-25
TR200101886T2 (tr) 2001-12-21
IL143958A0 (en) 2002-04-21
RU2001120016A (ru) 2003-12-10
EP1142872A4 (en) 2002-04-17
CN1178913C (zh) 2004-12-08
ATE411286T1 (de) 2008-10-15
AU1797900A (en) 2000-07-31
NO20013179D0 (no) 2001-06-22
AU763040B2 (en) 2003-07-10
EP1142872A1 (en) 2001-10-10
US6645956B1 (en) 2003-11-11
HUP0201472A3 (en) 2006-03-28
CZ20012160A3 (cs) 2001-10-17
CA2353961A1 (en) 2000-07-06
US20040002485A1 (en) 2004-01-01
CN1335834A (zh) 2002-02-13

Similar Documents

Publication Publication Date Title
NO20013179D0 (no) Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter
NO20042673L (no) Acetylenderivaer som har mGluR5 antagonistisk aktivitet
DK1104420T3 (da) Substituerede 1,8-naphthyridin-4(1H)-oner som phosphodiesterase-4-inhibitorer
AU2003257822A1 (en) Heterocyclic compound having hiv integrase inhibitory activity
NO20015078D0 (no) Sulfonamidderivater som har oksadiazolringer
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20032926L (no) Heterocykliske forbindelser som har antibakteriell aktivitet, fremgangsmåtefor deres fremstilling og farmasöytiske sammensetninger sominneholder dem
NO20011738D0 (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
DK0882024T3 (da) Forbindelser, som inhiberer retroviral protease
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
NO20030153L (no) Blandinger som inneholder terapeutisk aktive komponenter som har foröket löselighet
NO20004810D0 (no) HIV-inhiberende pyrimidinderivater
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
AU2001295310A1 (en) Aromatic derivatives with hiv integrase inhibitory properties
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
DE69906981D1 (de) Herbizide phenoxypropionsäure-n-alkyl-n-2-fluorophenylamid-verbindungen
NO20030100L (no) Pleuromutilinderivater som har antibakteriell aktivitet
AU2002349675A1 (en) Derivative having hiv integrase inhibitory activity
NO20032614L (no) Farmasöytisk sammensetning som har forbedret absorberbarhet
NO20013441D0 (no) Sammensetninger som har forbedret stabilitet
NO20020485D0 (no) Heterocykliske forbindelser som inhiberer angiogenese
DE60002655D1 (de) Modularer helm
NO972914D0 (no) Substituerte tiadiazoler, blandinger inneholdende dem og deres anvendelse som antimikrobielle og marine antibegroingsmidler
IT1308147B1 (it) Elemento attivo per tamburi fresanti dimacchine operatrici per la rimozione di suoli, provvisto di
PT1192154E (pt) Compostos de bispidina uteis para o tratamento de arritmias cardiacas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application